How to Buy Poseida Therapeutics Stock
Poseida Therapeutics Inc
Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs.
Poseida Therapeutics stock last closed at $2.77, up 14.46% from the previous day, and has increased 0.36% in one year. It has overperformed other stocks in the Biotechnology industry by 0.21 percentage points. Poseida Therapeutics stock is currently +79.87% from its 52-week low of $1.54, and -35.13% from its 52-week high of $4.27.
At the moment, there are 96.49M shares of PSTX outstanding. The market value of PSTX is $267.27M. In the past 24 hours, 2.85M PSTX shares were traded.
How to Buy Poseida Therapeutics Stock
Not sure how to invest in Poseida Therapeutics stock? Here's how.
- Decide where to buy Poseida Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Poseida Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Select your method of payment and add your info.
- Research Poseida Therapeutics stock: The Poseida Therapeutics ticker symbol is PSTX. Is Poseida Therapeutics stock a good investment? Should you buy shares of PSTX? How do PSTX's underlying business fundamentals look? Do top analysts think Poseida Therapeutics is a good buy? Why has PSTX's stock price moved recently? (Hint: Our stock market research website can help you decide if PSTX is a good stock to buy).
- Make your PSTX trade: Decide if you will purchase PSTX shares at the current market price or use a limit order to buy PSTX stock at a specific price.
- Track your investment in PSTX: Create a watchlist to keep track of your new investment in Poseida Therapeutics shares.
Step 1: Decide where to buy Poseida Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy PSTX stock.
Our favorite brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you'll need to fill out some personal information so you are able to invest in PSTX today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create your new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've created your account on the best free stock trading app, you can securely and quickly fund your account:
Watch the tutorial below if you need help transferring money into your brokerage account.
Step 4: Research Poseida Therapeutics stock
Once you have selected the best place to buy Poseida Therapeutics stock, it's absolutely critical to evaluate their stock before you buy, so you actually understand the risk and opportunity.
Poseida Therapeutics shares quick numbers
Poseida Therapeutics Due Diligence Checks
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on PSTX's stock page.
Is PSTX stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PSTX's true value.
Using relative valuations methods:
- PSTX could be undervalued based on its P/B ratio of 2.58x, relative to Biotechnology industry P/B ratio of 6.02x
You can do additional valuation research on PSTX's stock here.
Is PSTX a healthy company?
Positive Health Checks:
- Total PSTX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the PSTX balance sheet.
- PSTX has $212.20M in cash and short term investments. This is sufficient to cover its annual cash burn of $95.23M.
- There are more short-term assets than short-term liabilities on the PSTX balance sheet.
- PSTX has cash burn of 95233000. It has enough cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- PSTX has a relatively high debt to equity ratio of 1.64.
- PSTX profit margin has gone down from -49% to -190.8% in the past year.
Do Wall Street analysts think it's a good time to buy Poseida Therapeutics stock
Out of 2 sell side analysts who research PSTX, the consensus analyst rating on Poseida Therapeutics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Poseida Therapeutics stock forecast page.
PSTX Trading Indicators
PSTX Performance Numbers
Last year, PSTX revenue was $64.70M. In the past 2 year, PSTX's revenue has grown by 43.92% per year. This was faster than the Biotechnology industry average of 28.49%.
Learn more about PSTX's earnings and revenue performance here.
Are PSTX insiders buying or selling the stock?
In the past year, executives and large shareholders at PSTX have sold more shares than they have bought.
Mark J. Gergen, Executive Chairman of PSTX, was the latest PSTX insider to sell. They sold $141,068.41 worth of PSTX shares on Mar 1, 2024.
Learn more about who owns PSTX stock here.
Can I get consistent income from PSTX stock?
No, Poseida Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about PSTX
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your PSTX trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Track your investment in PSTX
Now that you own some shares in PSTX, you'll want to keep up with your stock purchase.
Put PSTX on a watchlist to track your PSTX stock.
PSTX Feed
How to Buy Stock in Poseida Therapeutics
To reiterate, here are the 6 steps to buy Poseida Therapeutics stock:
- Decide where to buy Poseida Therapeutics stock
- Sign up for your brokerage account
- Fund your brokerage account
- Research Poseida Therapeutics stock
- Make your PSTX trade
- Track your investment in PSTX
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Poseida Therapeutics, add PSTX to your watchlist by clicking the button below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.